首頁 > 市場調查報告書 > 製藥

歐洲智慧生命科學製造市場預測至 2028 年 - 區域分析 - 按組件（解決方案和服務）、技術、應用（製藥、生物製藥和醫療器材）

市場調查報告書

商品編碼

1393985

歐洲智慧生命科學製造市場預測至 2028 年 - 區域分析 - 按組件（解決方案和服務）、技術、應用（製藥、生物製藥和醫療器材）

Europe Smart Life Sciences Manufacturing Market Forecast to 2028 - Regional Analysis - by Component (Solutions and Services), Technology, Application (Pharma, Bio-Pharma, and Medical Device)

出版日期: 2023年10月11日 | 出版商:

The Insight Partners | 英文 195 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

歐洲智慧生命科學製造市場預計將從2023年的56.7919億美元成長到2033年的220.5287億美元。預計2023年至2033年CAGR為14.5%。

製藥 4.0 的採用不斷增加，推動歐洲智慧生命科學製造市場

科技在醫療保健領域一直發揮著重要作用，其中與腫瘤學、神經學和免疫學等其他領域相比，生物技術產業是資料分析領域最新技術進步中受益最大的領域。新興的資料科學技術也有助於生物技術產業的發展。生物技術實驗室的主要作用是生物體分析、新藥研究等。

現代資料分析工具使生物技術研究人員能夠創建預測分析模型，並最終使他們了解實現其預期目的和目標的最有效方法。大資料、人工智慧、虛擬實境、資料視覺化和資料安全是生物技術實驗室常用的技術。 Novozymes 是一家領先的生物技術公司，總部位於丹麥哥本哈根郊外的 Bagsværd，它採用了資料視覺化工具 Tableau，徹底改變了其資料分析和協作方法。 Tableau 幫助 Novozymes 將報表時間縮短了 90% 以上。它還協助公司部門內的策略決策，如銷售、原料採購、規劃和財務。此外，Tableau 還允許 Novozymes 的銷售人員與客戶分享關鍵見解，從而建立關係並提高收入績效。

阿斯特捷利康 (AstraZeneca, plc) 是一家英國-瑞典跨國製藥和生物技術公司，利用資料和技術來最大限度地縮短發現和交付潛在新藥的時間。該公司的研發部門嵌入了資料科學和人工智慧功能，使科學家能夠突破科學的界限，提供改變生活的藥物。他們將人工智慧應用於從目標識別到臨床試驗的整個發現和開發過程，以發現指導藥物發現和開發過程的新見解。

Atomwise 擁有在小分子藥物發現中使用人工智慧的專業知識。 2021 年 12 月，該公司宣布其新興合資公司的投資組合不斷擴大，研究計畫涵蓋腫瘤學、免疫學、傳染病、神經科學和凝血障礙。在傳染病領域，該公司宣布增加與世界RNA病毒專家Nito Panganiban新成立的合資公司vAirus。該合資企業將使用基於人工智慧的篩選來尋找小分子化合物，作為針對黃病毒的新型廣譜抗病毒藥物。電子健康記錄 (eHR) 等整合式巨量資料工具可以讓醫療保健專業人員輕鬆獲得全面的患者健康記錄，即使有關患者健康的資訊來自分散的來源。巨量資料支持的基因研究的其他進展可能會在對抗鐮狀細胞疾病、囊性纖維化和血友病等單基因疾病方面取得巨大進展。此類研究也可用於開發針對精神疾病和心臟病等複雜疾病的改良治療和預防策略。

歐洲智慧生命科學製造市場概況

歐洲是智慧生命科學製造的已開發地區之一，工業4.0是德國政府於2011年啟動的第四次革命，描述製造過程中的數位化變革。國際製藥工程學會（ISPE）於2017年推出Pharma 4.0，全面推動藥廠數位化技術的實施。由於智慧製造的高度實施，該地區智慧生命科學製造發生了重大變化，生命科學製造商之間的合作可能會在未來幾年推動歐洲市場的成長。 2020 年 5 月，歐洲最大的製藥製造商之一 Adamed Group 與 Predica 合作部署 Microsoft Azure 雲端平台，包括安全性、資料分析、機器學習和應用程式開發。 Predica 設計並開發了一個基於 Azure資料服務和 Power BI 的完全可擴展平台，幫助 Adamed 產生自動預測並最佳化其供應鏈和行銷決策。此外，2022 年，來自葡萄牙的合約開發和製造組織 (CDMO) 之一 Hovione 與 GEA 合作推進連續壓片。此次策略合作將 GEA 的工程專業知識與 Hovione 的開發和製造經驗結合，雙方承諾合作加速連續壓片技術的採用。

COVID-19 大流行增加了智慧製造技術的採用和實施，特別是在呼吸機、病床、藥物和疫苗的生產方面。這導致該地區醫療器材和藥品生產和核准的監管政策發生重大變化。歐洲議會已用法規取代了醫療器材指令。由於疫情的影響，製造商修改了該地區法規的適用規定。對於低風險器械，從指令到監管的過渡期延長至2027年5月，對於中風險器械，該過渡期延長至2026年5月。此外，高風險器械的過渡期延長至2025年5月。醫療器械中的數位自動化有助於遵守法規並輕鬆處理核准，從而減少核准時間並有助於及時推出產品。不斷變化的監管環境、生命科學製造中數位技術的高採用率以及市場參與者之間不斷加強的合作預計將在預測期內增強歐洲智慧生命科學製造市場的成長。

歐洲智慧生命科學製造市場收入及 2033 年預測（百萬美元）

歐洲智慧生命科學製造市場區隔

歐洲智慧生命科學製造市場分為技術、組件、應用和國家。

根據組件，歐洲智慧生命科學製造市場分為解決方案和服務。 2023年，解決方案領域在歐洲智慧生命科學製造市場中佔有更大佔有率。

根據技術，歐洲智慧生命科學製造細分市場分為AR/VR系統、物聯網（IoT）、人工智慧（AI）、網路安全、巨量資料等。 2023年，物聯網領域在歐洲智慧生命科學製造市場中佔有最大佔有率。

根據應用，歐洲智慧生命科學製造市場分為製藥、生物製藥和醫療器材。 2023年，醫療器材領域在歐洲智慧生命科學製造市場中佔最大佔有率。

依國家/地區分類，歐洲智慧生命科學製造市場分為德國、法國、義大利、西班牙、英國和歐洲其他地區。 2023年，德國在歐洲智慧生命科學製造市場佔據主導地位。

ABB Ltd、Bosch Rexroth AG、艾默生電氣公司、Fortinet Inc、通用電氣公司、霍尼韋爾國際公司、國際商業機器公司、羅克韋爾自動化公司、西門子公司和Sophos Ltd 是歐洲智慧生命科學領域的一些領先公司製造市場。

市場促進因素
- 製藥 4.0 的採用率不斷上升
- 生物技術實驗室擴大使用技術
市場限制
- 存在技能差距和需要高額初始投資
市場機會
- 人工智慧在癌症研究的應用
- 智慧工廠採用虛擬實境
未來的趨勢
- 連接到資料孤島
- 區塊鏈的使用
- 邊緣運算
- 預測性維護
- 基於願景的品質管理
- 智慧工廠趨勢
- 工業5.0的出現
促進因素和限制因素的影響分析

第 6 章：歐洲智慧生命科學製造市場 - 歐洲分析

概述

第 7 章：歐洲智慧生命科學製造市場分析 - 按組成部分

概述
歐洲智慧生命科學製造市場，按組成部分（2022 年和 2033 年）
解決方案
服務

第 8 章：歐洲智慧生命科學製造市場分析 - 按技術

概述
歐洲智慧生命科學製造市場，依技術分類（2022 年和 2033 年）
AR/VR系統
物聯網 (IOT)
人工智慧
網路安全
巨量資料
其他

第 9 章：歐洲智慧生命科學製造市場分析 - 按最終用途產業

概述
歐洲智慧生命科學製造市場，依最終用途產業分類（2022 年和 2033 年）
製藥公司
生物製藥
醫療裝置

第 10 章：歐洲智慧生命科學製造市場分析 - 按國家/地區

歐洲智慧生命科學製造市場概況

第 11 章：產業格局

概述
市場計劃、擴張和策略發展
新產品/功能開發
併購
協議、合作和合資企業

第 12 章：公司簡介

ABB Ltd
Bosch Rexroth AG
Emerson Electric Co
Fortinet Inc
General Electric Co
Honeywell International Inc
International Business Machines Corp
Rockwell Automation Inc
Siemens AG
Sophos Ltd.

第 13 章：附錄

關於 Insight Partners
詞索引

簡介目錄圖表

Product Code: BMIRE00028923

The Europe smart life sciences manufacturing market is expected to grow from US$ 5,679.19 million in 2023 to US$ 22052.87 million by 2033. It is estimated to grow at a CAGR of 14.5% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel Europe Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the biotechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by biotechnology laboratories.

Modern data analytics tools have allowed biotechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Novozymes, a leading biotechnology company headquartered in Bagsværd, just outside of Copenhagen, Denmark, has adopted Tableau, a data visualization tool, which revolutionized its approach to data analysis and collaboration. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British-Swedish multinational pharmaceutical and biotechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process.

Atomwise has expertise in using AI in small-molecule drug discovery. In December 2021, the company announced its growing portfolio of emerging joint venture companies, with research programs spanning oncology, immunology, infectious disease, neuroscience, and clotting disorders. In the area of infectious disease, the company announced the addition of vAirus, a newly formed joint venture company with world RNA-virus expert Nito Panganiban. The joint venture will use AI-based screening to find small molecule compounds to act as novel broad-spectrum antivirals against flaviviruses. Integrated big data tools such as electronic health records (eHR) can make it easy for healthcare professionals to obtain a comprehensive patient health record, even if information regarding their health originates from scattered sources. Other advances in genetic research backed by big data could lead to dramatic progress in the fight against single-gene disorders, such as sickle cell disease, cystic fibrosis, and hemophilia. This type of research can also be employed to develop improved treatments and prevention strategies for complex conditions such as mental illness and heart disease.

Europe Smart Life Sciences Manufacturing Market Overview

Europe is one of the developed regions for smart life sciences manufacturing, and Industry 4.0 is the fourth revolution started in 2011 by the German government to describe the digital changes in the manufacturing process. The International Society of Pharmaceutical Engineering (ISPE) introduced Pharma 4.0 in 2017, which takes a holistic approach to the implementation of digital technology in pharmaceutical enterprises. The region has seen significant changes in smart life sciences manufacturing owing to the high implementation of smart manufacturing and collaborations among life sciences manufacturers are likely to propel the market growth in Europe in the coming years. In May 2020, Adamed Group, one of the largest pharmaceutical manufacturers in Europe, partnered with Predica for the deployment of Microsoft Azure cloud platform, including security, data analytics, machine learning, and app development. Predica designed and developed a fully extensible platform based on Azure data services and Power BI that helped Adamed generate automated forecasts and optimize its supply chain and marketing decisions. Additionally, in 2022, Hovione, one the Contract Development and Manufacturing Organization (CDMO) from Portugal, collaborated with GEA to advance continuous tableting. This strategic collaboration combines GEA's engineering expertise with Hovione's development and manufacturing experience, and both parties commit to partner to accelerate the adoption of continuous tableting technology.

COVID-19 pandemic has increased the adoption and implementation of smart manufacturing technologies, especially for the production of ventilators, hospital beds, drugs, and vaccines. This led to a significant change in the regulatory policies of the region for the production and approval of medical devices and drugs. The European Parliament has replaced medical device directives with regulations. Owing to the pandemic, the manufacturers have amended provisions for the application of regulations in the region. For low-risk devices, the transition period from directive to regulation is extended until May 2027, and for moderate-risk devices, the period is extended until May 2026. Also, the transition period for high-risk devices is extended until May 2025. Digital automation in medical devices helps comply with the regulation and easily process approval, which reduces the approval time and assists in timely product launches. The changing regulatory scenario, high adoption rate of digital technology in life sciences manufacturing, and rising collaborations among market players are expected to augment the Europe smart life sciences manufacturing market growth in Europe during the forecast period.

Europe Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)

Europe Smart Life Sciences Manufacturing Market Segmentation

The Europe smart life sciences manufacturing market is segmented into technology, component, application, and country.

Based on component, the Europe smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the Europe smart life sciences manufacturing Market in 2023.

Based on technology, the Europe smart life sciences manufacturing market segment is categorized into AR/VR Systems, Internet of things (IoT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of Things segment held the largest share of the Europe smart life sciences manufacturing market in 2023.

Based on application, the Europe smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical devices segment held the largest share of the Europe smart life sciences manufacturing market in 2023.

Based on country, the Europe smart life sciences manufacturing market is segmented into Germany, France, Italy, Spain, the UK, and the Rest of Europe. Germany dominated the Europe smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the Europe smart life sciences manufacturing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe Smart Life Sciences Manufacturing Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Europe Smart Life Sciences Manufacturing Market - By Component
- 1.3.2 Europe Smart Life Sciences Manufacturing Market - By Technology
- 1.3.3 Europe Smart Life Sciences Manufacturing Market - By End Use Industry
- 1.3.4 Europe Smart Life Sciences Manufacturing Market - By Country

2. Europe Smart Life Sciences Manufacturing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Smart Life Sciences Manufacturing Market - Market Landscape

4.1 Overview
4.2 Europe PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion

5. Europe Smart Life Sciences Manufacturing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Adoption of Pharma 4.0
- 5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
5.2 Market Restraints
- 5.2.1 Presence of Skill Gap and Need for High Initial Investment
5.3 Market Opportunities
- 5.3.1 Use of Artificial Intelligence in Cancer Research
- 5.3.2 Adoption of Virtual Reality in Smart Factory
5.4 Future Trends
- 5.4.1 Connection to Data Silos
- 5.4.2 Usage of Blockchain
- 5.4.3 Edge Computing
- 5.4.4 Predictive Maintenance
- 5.4.5 Vision-Based Quality Management
- 5.4.6 Smart Factory Trends
- 5.4.7 Emergence of Industry 5.0
5.5 Impact Analysis of Drivers and Restraints

6. Europe Smart Life Sciences Manufacturing Market - Europe Analysis

6.1 Overview
6.2 Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

7. Europe Smart Life Sciences Manufacturing Market Analysis - By Component

7.1 Overview
7.2 Europe Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
7.3 Solutions
- 7.3.1 Overview
- 7.3.2 Solutions: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
- 7.4.1 Overview
- 7.4.2 Services: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

8. Europe Smart Life Sciences Manufacturing Market Analysis - By Technology

8.1 Overview
8.2 Europe Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
8.3 AR/VR System
- 8.3.1 Overview
- 8.3.2 AR/VR System: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.4 Internet of Things (IOT)
- 8.4.1 Overview
- 8.4.2 Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.5 Artificial Intelligence
- 8.5.1 Overview
- 8.5.2 Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.6 Cyber Security
- 8.6.1 Overview
- 8.6.2 Cyber Security: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.7 Big Data
- 8.7.1 Overview
- 8.7.2 Big Data: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

9. Europe Smart Life Sciences Manufacturing Market Analysis - By End Use Industry

9.1 Overview
9.2 Europe Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
9.3 Pharma
- 9.3.1 Overview
- 9.3.2 Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.4 Bio-Pharma
- 9.4.1 Overview
- 9.4.2 Bio-Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.5 Medical Device
- 9.5.1 Overview
- 9.5.2 Medical Device: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

10. Europe Smart Life Sciences Manufacturing Market Analysis - By Country

10.1 Europe Smart Life Sciences Manufacturing Market Overview

11. Industry Landscape

11.1 Overview
11.2 Market Initiatives, Expansions, and Strategic Developments
11.3 New Product/Feature Development
11.4 Mergers and Acquisitions
11.5 Agreements, Collaborations, and Joint Ventures

12. Company Profile

12.1 ABB Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bosch Rexroth AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emerson Electric Co
- 12.3.1 Business Description
- 12.3.2 Products and Services
- 12.3.3 Financial Overview
- 12.3.4 SWOT Analysis
- 12.3.5 Key Developments
12.4 Fortinet Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 General Electric Co
- 12.5.1 Business Description
- 12.5.2 Products and Services
- 12.5.3 Financial Overview
- 12.5.4 SWOT Analysis
- 12.5.5 Key Developments
12.6 Honeywell International Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 International Business Machines Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Rockwell Automation Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Siemens AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Sophos Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Word Index

簡介目錄圖表

List Of Tables

Table 1. Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Table 2. Germany Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 3. Germany Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 4. Germany Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 5. Germany Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 6. France Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 7. France Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 8. France Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 9. France Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 10. Italy Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 11. Italy Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 12. Italy Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 13. Italy Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 14. UK Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 15. UK Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 16. UK Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 17. UK Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 18. Spain Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 19. Spain Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 20. Spain Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 21. Spain Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 22. Rest of Europe Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 23. Rest of Europe Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 24. Rest of Europe Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 25. Rest of Europe Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 26. List of Abbreviation

List Of Figures

Figure 1. Europe Smart Life Sciences Manufacturing Market Segmentation
Figure 2. Europe Smart Life Sciences Manufacturing Market Segmentation, By Country
Figure 3. Europe Smart Life Sciences Manufacturing Market Overview
Figure 4. Solutions Held Largest Share of Component Segment in Europe Smart Life Sciences Manufacturing Market
Figure 5. Europe Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Europe Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
Figure 9. Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 10. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
Figure 11. Solutions: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Services: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 13. Europe Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
Figure 14. AR/VR System: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Internet of Things (IOT): Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Artificial Intelligence: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 17. Cyber Security: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 18. Big Data: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 19. Others: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 20. Europe Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
Figure 21. Pharma: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 22. Bio-Pharma : Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 23. Medical Device: Europe Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 24. Europe Smart Life Sciences Manufacturing Market, by Key Country - Revenue (2022) (US$ Million)
Figure 25. Europe Smart Life Sciences Manufacturing Market, Revenue Share, by Key Country, (2022 & 2033)
Figure 26. Germany: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 27. France: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 28. Italy: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 29. UK: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 30. Spain: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 31. Rest of Europe: Europe Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)